Cargando…
Prediction of Potential Commercially Available Inhibitors against SARS-CoV-2 by Multi-Task Deep Learning Model
The outbreak of COVID-19 caused millions of deaths worldwide, and the number of total infections is still rising. It is necessary to identify some potentially effective drugs that can be used to prevent the development of severe symptoms, or even death for those infected. Fortunately, many efforts h...
Autores principales: | Hu, Fan, Jiang, Jiaxin, Yin, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405964/ https://www.ncbi.nlm.nih.gov/pubmed/36009050 http://dx.doi.org/10.3390/biom12081156 |
Ejemplares similares
-
Multi-PLI: interpretable multi‐task deep learning model for unifying protein–ligand interaction datasets
por: Hu, Fan, et al.
Publicado: (2021) -
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones
por: Chaves, Otávio Augusto, et al.
Publicado: (2022) -
Validation of a commercially available SARS-CoV-2 serological immunoassay
por: Meyer, B., et al.
Publicado: (2020) -
Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
por: Weidner, Lisa, et al.
Publicado: (2020) -
Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes
por: Davies, Katherine, et al.
Publicado: (2021)